Applied Genetic Technologies (NASDAQ: AGTC) reported Q3 EPS of ($0.38), $0.05 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $284 thousand versus the consensus estimate of $580 thousand.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.